Barely Significant
← all excerpts

The Telomere Length Signature in Leukemias-From Molecular Mechanisms Underlying Telomere Shortening to Immunotherapeutic Options Against Telomerase.

Cancers (Basel) · 2025 · PMC12190229 · PMID 40563586

1
hedged sentence
closest p
boldest claim

The sentences

a decreasing trendno p-value reported
Consistent with this, telomere length values were also observed to be higher in AML, and the telomere length values followed a decreasing trend first in T-cell ALL and then in B-cell ALL, confirming the reversing action of telomerase against telomere shortening [ 186 ].

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.